ARCHIVES

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

PDX Shows 27% Response In T-Cell Lymphoma In Study

December 26, 2008

In Brief: DeVita Vs. Lincoln; ACS Says It Will Take “New Initiatives In Political Forums”

March 17, 1978

Obama Calls for Bigger Investment in Science, GOP Plans Cuts

January 28, 2011

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

In Brief: Wells Tapped For GM Cancer Foundation; Calder Named NABCO Associate Director

January 17, 1997

NIH Workshop On Animal Care Planned

May 4, 1990